These benefits, together with a past report showing that a little-molecule ACKR3 agonist CCX771 displays anxiolytic-like conduct in mice,2 assist the strategy of targeting ACKR3 as a novel strategy to modulate the opioid system, which could open up new therapeutic avenues for opioid-related Problems. Take note: Results might range https://fionac368qpl9.wikimillions.com/user